![Dinah Sah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dinah Sah
Direktor/Vorstandsmitglied bei
CIRCIO HOLDING ASA
Profil
Dinah W.
Y.
Sah is currently Director at Circio Holding ASA since 2026 and Scientific Advisor at VV Manager LLC.
Former positions include Associate Director-Research at Biogen, Inc. from 1999 to 2005, Associate Director-Neurobiology at Signal Pharmaceuticals, Inc. in 1999, President and Director at TrustArc, Inc., Vice President-Research at Alnylam Pharmaceuticals, Inc. from 2010 to 2012, and Chief Scientific Officer at Voyager Therapeutics, Inc. from 2017 to 2019.
Education includes a doctorate from Harvard University and an undergraduate degree from Massachusetts Institute of Technology.
Aktive Positionen von Dinah Sah
| Unternehmen | Position | Beginn |
|---|---|---|
| CIRCIO HOLDING ASA | Direktor/Vorstandsmitglied | 25.08.2026 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Berater | - |
Ehemalige bekannte Positionen von Dinah Sah
| Unternehmen | Position | Ende |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.06.2019 |
| ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
| BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Corporate Officer/Principal | 01.01.1999 |
TrustArc, Inc.
 TrustArc, Inc. Packaged SoftwareTechnology Services Develops an AI-powered data privacy and compliance management platform | Präsident | - |
Ausbildung von Dinah Sah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
TrustArc, Inc.
TrustArc, Inc. Packaged SoftwareTechnology Services Develops an AI-powered data privacy and compliance management platform | Technology Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
